SQ-31765

• Description:

  SQ-31765 is a benzazepine calcium channel blocker.

• UNSPSC:

  12352005

• Hazard Statement:

  H302-H315-H319-H335

• Target:

  Calcium Channel

• Type:

  Reference compound

• Related Pathways:

  Membrane Transporter/Ion Channel; Neuronal Signaling

• Applications:

  Neuroscience-Neuromodulation

• Field of Research:

  Cardiovascular Disease

• Assay Protocol:

  https://www.medchemexpress.com/SQ-31765.html

• Solubility:

  10 mM in DMSO

• Smiles:

  O=C1N(CCN(C)C)C2=CC=CC(C(F)(F)F)=C2C[C@@H](C3=CC=C(OC)C=C3)[C@H]1OC(C)=O

• Molecular Formula:

  C24H27F3N2O4

• Molecular Weight:

  464.48

• Precautions:

  P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P330-P362+P364-P403+P233-P405-P501

• References & Citations:

  [1]Grover GJ, et al. Anti-ischemic and vasorelaxant effects of the new benzazepine calcium channel blocker SQ 31,765. J Pharmacol Exp Ther. 1989 Dec;251 (3) :1020-5.

• Shipping Conditions:

  Room temperature

• Scientific Category:

  Reference compound1

• Clinical Information:

  No Development Reported

• CAS Number:

  [138383-07-0]